Treatment of Overactive Bladder With a Digital Conversational Agent: the MOTIVATION Study

Inclusion Criteria: * Symptoms of overactive bladder with urgency urinary incontinence, with or without nocturia/nocturnal enuresis * Symptoms of mixed urinary incontinence if urgency incontinence is the predominant complaint * Post-void residual \<100ml * English speaking * Access to a smartphone * Normal urinalysis without evidence of UTI, gross or microscopic hematuria * Greater than 6 months since receiving intradetrusor injection of botulinum toxin * Not currently undergoing sacral neuromodulation therapy * Not currently receiving pharmacotherapy for overactive bladder Exclusion Criteria: * Less than 40 years of age * Mixed incontinence with predominant stress urinary incontinence symptoms * Diagnosis of chronic pelvic pain * symptomatic pelvic organ prolapse * symptoms of dysuria * Diagnosis of interstitial cystitis/painful bladder syndrome * Reported \>2 UTI in 6 months or \>3 in 12 months * Do not have access to a smartphone * Non-English speaking * Diagnosis of neurogenic bladder * Gross or microscopic hematuria * Has diagnosis of dementia, cognitive impairment or other neurologic condition which impairs decision making * Current Pharmacotherapy or neuromodulation therapy * Less than 6 months since intradetrusor botulinum toxin injection * Has decreased mobility or ambulation * Has post-void residual \>100 mL * Has BMI \> 40 kg/m\^2 * Inability to voluntarily contract the pelvic floor muscles (a 0/5 in strength). * Has \>4/10 pain with palpation of levator ani, coccygeus, pyriformis, obturator internus or perineal body